Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP913996.RAP07fMDKH3tuG4MZcDYiYLblLy3IGMxZTRFsrR64bkwo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP913996.RAP07fMDKH3tuG4MZcDYiYLblLy3IGMxZTRFsrR64bkwo130_assertion type Assertion NP913996.RAP07fMDKH3tuG4MZcDYiYLblLy3IGMxZTRFsrR64bkwo130_head.
- NP913996.RAP07fMDKH3tuG4MZcDYiYLblLy3IGMxZTRFsrR64bkwo130_assertion description "[Donor leukocyte infusion (DLI) is closely associated with development of graft-versus-host disease (GVHD) and has well-defined activity against relapsed chronic myelogenous leukemia (CML) but not ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913996.RAP07fMDKH3tuG4MZcDYiYLblLy3IGMxZTRFsrR64bkwo130_provenance.
- NP913996.RAP07fMDKH3tuG4MZcDYiYLblLy3IGMxZTRFsrR64bkwo130_assertion evidence source_evidence_literature NP913996.RAP07fMDKH3tuG4MZcDYiYLblLy3IGMxZTRFsrR64bkwo130_provenance.
- NP913996.RAP07fMDKH3tuG4MZcDYiYLblLy3IGMxZTRFsrR64bkwo130_assertion SIO_000772 11840146 NP913996.RAP07fMDKH3tuG4MZcDYiYLblLy3IGMxZTRFsrR64bkwo130_provenance.
- NP913996.RAP07fMDKH3tuG4MZcDYiYLblLy3IGMxZTRFsrR64bkwo130_assertion wasDerivedFrom befree-20140225 NP913996.RAP07fMDKH3tuG4MZcDYiYLblLy3IGMxZTRFsrR64bkwo130_provenance.
- NP913996.RAP07fMDKH3tuG4MZcDYiYLblLy3IGMxZTRFsrR64bkwo130_assertion wasGeneratedBy ECO_0000203 NP913996.RAP07fMDKH3tuG4MZcDYiYLblLy3IGMxZTRFsrR64bkwo130_provenance.